Filing Summary
Business context and reporting period
This Form 8-K was filed by NextGen Acquisition Corporation, not Xos, Inc., and reports events occurring on October 9, 2020. NextGen was a special purpose acquisition company (SPAC) that completed its initial public offering (IPO). The filing does not describe Xos, Inc. or an operating business combination.
Key financial metrics and capitalization
- IPO: 35,000,000 units sold at $10.00 per unit, generating gross proceeds of $350,000,000.
- Each unit consisted of one Class A ordinary share and one-third of one redeemable warrant.
- Each whole public warrant was exercisable for one Class A ordinary share at $11.50 per share, subject to adjustment.
- Private placement: 6,000,000 warrants sold to NextGen Sponsor LLC at $1.50 per warrant, generating gross proceeds of $9,000,000.
- The filing states that $350,000,000 of proceeds from the IPO and private warrant sale was deposited into a U.S.-based trust account at JPMorgan Chase Bank, N.A.
- No revenue, operating profit, net income, cash flow, margins, debt, or liquidity ratios are reported because this filing concerns the SPAC’s IPO and trust-account funding rather than operating results.
Changes, outlook, risks, and unusual items
The material event was the completion of the IPO and concurrent private placement. The filing does not provide prior-period operating comparisons, management guidance, or an identified target acquisition. The trust account structure and redeemable warrants are unusual items relevant to the SPAC’s future capital allocation and potential business combination.
An audited balance sheet as of October 9, 2020 was filed as Exhibit 99.1. The supplied filing text does not provide its detailed balance-sheet values.
Investor verification checklist
- Verify the issuer identity: the filing names NextGen Acquisition Corporation, while the request metadata identifies Xos, Inc.
- Review Exhibit 99.1 for the audited balance sheet, including cash, offering costs, warrant liabilities, and shareholders’ equity.
- Confirm the amount and terms of the trust account and the conditions governing its release.
- Review the public and private warrant terms, including exercise price, redemption provisions, and potential dilution.
- Determine whether a subsequent filing identifies a proposed business combination or target company.